Cargando…
Mutant AKT1-E17K is oncogenic in lung epithelial cells
The hotspot E17K mutation in the pleckstrin homology domain of AKT1 occurs in approximately 0.6–2% of human lung cancers. In this manuscript, we sought to determine whether this AKT1 variant is a bona-fide activating mutation and plays a role in the development of lung cancer. Here we report that in...
Autores principales: | De Marco, Carmela, Malanga, Donatella, Rinaldo, Nicola, De Vita, Fernanda, Scrima, Marianna, Lovisa, Sara, Fabris, Linda, Carriero, Maria Vincenza, Franco, Renato, Rizzuto, Antonia, Baldassarre, Gustavo, Viglietto, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741851/ https://www.ncbi.nlm.nih.gov/pubmed/26053093 |
Ejemplares similares
-
Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer
por: De Marco, Carmela, et al.
Publicado: (2017) -
AKT1(E17K) Is Oncogenic in Mouse Lung and Cooperates with Chemical Carcinogens in Inducing Lung Cancer
por: Malanga, Donatella, et al.
Publicado: (2016) -
Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells
por: Guerriero, Ilaria, et al.
Publicado: (2016) -
Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer
por: De Marco, Carmela, et al.
Publicado: (2021) -
Correction: Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells
por: Guerriero, Ilaria, et al.
Publicado: (2022)